GlobalData on MSN
Sacral neuromodulation: broadening Boston Scientific’s European urology portfolio
Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20 ® ...
The Axonics System also features many other differentiating attributes, including a patented tined lead, a wireless charging system optimized for infrequent charging, a key fob size easy-to-use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results